Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
levosimendan (1 trial)
endostatin (endostar) (1 trial)
lapatinib (tykerb) (1 trial)
Aortic Valve Stenosis (Phase 4)
Constriction, Pathologic (Phase 4)
Head and Neck Neoplasms (Phase 2)
Heart Failure (Phase 4)
Nasopharyngeal Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (3 total)